635 related articles for article (PubMed ID: 16786772)
21. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
Lee HK; Adams MT; Motta J
Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
[TBL] [Abstract][Full Text] [Related]
22. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
Moinpour CM; Hayden KA; Unger JM; Thompson IM; Redman MW; Canby-Hagino ED; Higgins BA; Sullivan JW; Lemmon D; Breslin S; Crawford ED; Southwest Oncology Group
J Clin Oncol; 2008 Jan; 26(1):112-20. PubMed ID: 18165645
[TBL] [Abstract][Full Text] [Related]
24. Locally advanced prostate cancer: effective treatments, but many adverse effects.
Prescrire Int; 2013 Jan; 22(134):18-20, 22-3. PubMed ID: 23367679
[TBL] [Abstract][Full Text] [Related]
25. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
26. [Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
Iwasawa T; Matsumoto H
Hinyokika Kiyo; 1996 Nov; 42(11):869-74. PubMed ID: 8973937
[TBL] [Abstract][Full Text] [Related]
27. [What is the best strategy of hormonal therapy in the treatment of locally advanced prostate cancer?].
Ehara H; Nakano M; Deguchi T
Hinyokika Kiyo; 2006 Jun; 52(6):473-7. PubMed ID: 16848361
[TBL] [Abstract][Full Text] [Related]
28. The challenge of locally advanced prostate cancer.
Pisters LL
Semin Oncol; 1999 Apr; 26(2):202-16. PubMed ID: 10597731
[TBL] [Abstract][Full Text] [Related]
29. Randomized controlled trial to evaluate radiotherapy +/- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG 0401.
Yokomizo A; Kawamoto H; Nihei K; Ishizuka N; Kakehi Y; Tobisu K; Naito S;
Jpn J Clin Oncol; 2005 Jan; 35(1):34-6. PubMed ID: 15681602
[TBL] [Abstract][Full Text] [Related]
30. Combination hormonal therapy: a reassessment within advanced prostate cancer.
Moul JW; Chodak G
Prostate Cancer Prostatic Dis; 2004 Sep; 7 Suppl 1():S2-7. PubMed ID: 15365575
[TBL] [Abstract][Full Text] [Related]
31. [Indications of the association of radiotherapy and hormonal treatment in prostate cancer].
Bolla M; Maingon P; Fourneret P; Artignan X; Descotes JL
Cancer Radiother; 2005 Nov; 9(6-7):394-8. PubMed ID: 16226044
[TBL] [Abstract][Full Text] [Related]
32. [Preliminary results of radical surgery and radiotherapy of locally advanced prostate cancer (basal PSA >50 ng/ml)].
Kaprin AD; Khmelevskiĭ EV; Fadeev AV
Vopr Onkol; 2007; 53(4):479-81. PubMed ID: 17969415
[TBL] [Abstract][Full Text] [Related]
33. [Postoperative radiotherapy of prostate cancer].
Richaud P; Sargos P; Henriques de Figueiredo B; Latorzeff I; Mongiat-Artus P; Houédé N; Salomon L; Wallerand H
Cancer Radiother; 2010 Oct; 14(6-7):500-3. PubMed ID: 20810300
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant Hormonal Treatment with Radiotherapy for Locally Advanced Prostate Cancer.
Bolla M
Eur Urol; 1998 Dec; 35 Suppl S1():23-26. PubMed ID: 9858848
[TBL] [Abstract][Full Text] [Related]
35. Management of locally advanced prostate cancer: a European consensus.
Boccon-Gibod L; Bertaccini A; Bono AV; Dev Sarmah B; Höltl W; Mottet N; Tunn U; Zamboglou N
Int J Clin Pract; 2003 Apr; 57(3):187-94. PubMed ID: 12723722
[TBL] [Abstract][Full Text] [Related]
36. [Neoadjuvant hormonal therapy for prostate cancer].
Miki T; Kamoi K
Gan To Kagaku Ryoho; 2001 Jul; 28(7):927-33. PubMed ID: 11478141
[TBL] [Abstract][Full Text] [Related]
37. Biological optimization of the dose in prostate cancer.
Morganti AG; Mantini G; Luzi S; Errico A; Digesù C; Mattiucci GC
Rays; 2004; 29(3):309-18. PubMed ID: 15603303
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
39. The case for adjuvant therapy for prostate cancer.
Glodé LM
J Urol; 2006 Dec; 176(6 Pt 2):S30-3. PubMed ID: 17084163
[TBL] [Abstract][Full Text] [Related]
40. Clinical strategies for improving the radiotherapeutic management of prostate cancer.
Chuba PJ; Forman JD; Ben-Josef E; Hart KH; Porter AT
Anticancer Res; 1997; 17(3A):1449-54. PubMed ID: 9179182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
